Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the ikaros gene

Pediatric Blood and Cancer

Volumn 58, Issue 4, 2012, Pages 591-597

  Goldman, Frederick D ^a   Gurel, Zafer ^b   Al Zubeidi, Duha ^c   Fried, Ari J ^d   Icardi, Michael ^e   Song, Chunhua ^f   Dovat, Sinisa ^f,g  

^a CHILDREN S HOSPITAL OF ALABAMA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^f PENN STATE COLLEGE OF MEDICINE   (United States)

^g PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

B lymphopenia; Hematopoiesis; Ikaros; Pancytopenia

Indexed keywords

ANTIBIOTIC AGENT; CD45RO ANTIGEN; CD69 ANTIGEN; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IKAROS TRANSCRIPTION FACTOR; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ALPHA; MELPHALAN; METHOTREXATE; THYMOCYTE ANTIBODY;

ALLELE; ALLOGENIC BONE MARROW TRANSPLANTATION; APGAR SCORE; ARTICLE; B LYMPHOCYTE; BONE MARROW APLASIA; CD3+ T LYMPHOCYTE; CELLULITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORDOCENTESIS; DNA BINDING; EXON; FANCONI ANEMIA; FETUS HYDROPS; GENE SEQUENCE; GENETIC ASSOCIATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDRAMNIOS; IMMUNOPHENOTYPING; INFANT; KIDNEY FAILURE; LYMPHOCYTOPENIA; MALE; MULTIPLE ORGAN FAILURE; MYELOPOIESIS; NATURAL KILLER CELL; NEUTROPHIL COUNT; POINT MUTATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

AMINO ACID SUBSTITUTION; ANIMALS; B-LYMPHOCYTES; BONE MARROW; GENETIC DISEASES, INBORN; GESTATIONAL AGE; HUMANS; IKAROS TRANSCRIPTION FACTOR; INFANT, NEWBORN; LEUKOCYTE COUNT; MALE; MICE; MICE, KNOCKOUT; MYELOPOIESIS; PANCYTOPENIA; PHENOTYPE; POINT MUTATION; SEVERE COMBINED IMMUNODEFICIENCY; ZINC FINGERS;

EID: 84856909174     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23160     Document Type: Article

References (40)

1. Georgopoulos K, Moore DD, Derfler B. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 1992; 258: 808-812.
2. Yu S, Asa SL, Ezzat S. Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary. Mol Endocrinol 2002; 16: 1069-1078.
3. Molnar A, Georgopoulos K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 1994; 14: 8292-8303.
4. Sun L, Liu A, Georgopoulos K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 1996; 15: 5358-5369.
5. Brown KE, Guest SS, Smale ST, et al. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 1997; 91: 845-854.
6. Trinh LA, Ferrini R, Cobb BS, et al. Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev 2001; 15: 1817-1832.
7. Sabbattini P, Lundgren M, Georgiou A, et al. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J 2001; 20: 2812-2822.
8. Koipally J, Renold A, Kim J, et al. Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J 1999; 18: 3090-3100.
9. Koipally J, Georgopoulos K. Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity. J Biol Chem 2000; 275: 19594-19602.
10. Kim J, Sif S, Jones B, et al. Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 1999; 10: 345-355.
11. Mullighan CG, Goorha S, Radtke I, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758-764.
12. Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008; 453: 110-114.
13. Kuiper RP, Schoenmakers EF, van Reijmersdal SV, et al. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia 2007; 21: 1258-1266.
14. Sun L, Heerema N, Crotty L, et al. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1999; 96: 680-685.
15. Nakase K, Ishimaru F, Avitahl N, et al. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Res 2000; 60: 4062-4065.
16. Crescenzi B, La Starza R, Romoli S, et al. Submicroscopic deletions in 5q- associated malignancies. Haematologica 2004; 89: 281-285.
17. Yagi T, Hibi S, Takanashi M, et al. High frequency of Ikaros isoform 6 expression in acute myelomonocytic and monocytic leukemias: Implications for up-regulation of the antiapoptotic protein Bcl-XL in leukemogenesis. Blood 2002; 99: 1350-1355.
18. Nakayama H, Ishimaru F, Avitahl N, et al. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. Cancer Res 1999; 59: 3931-3934.
19. Georgopoulos K, Bigby M, Wang JH, et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994; 79: 143-156.
20. Dumortier A, Kirstetter P, Kastner P, et al. Ikaros regulates neutrophil differentiation. Blood 2003; 101: 2219-2226.
21. Gurel Z, Ronni T, Ho S, et al. Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation. J Biol Chem 2008; 283: 8291-8300.
22. Ronni T, Payne KJ, Ho S, et al. Human Ikaros function in activated T cells is regulated by coordinated expression of its largest isoforms. J Biol Chem 2007; 282: 2538-2547.
23. Popescu M, Gurel Z, Ronni T, et al. Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1. J Biol Chem 2009; 284: 13869-13880.
24. Liberg D, Smale ST, Merkenschlager M. Upstream of Ikaros. Trends Immunol 2003; 24: 567-570.
25. Cobb BS, Morales-Alcelay S, Kleiger G, et al. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding. Genes Dev 2000; 14: 2146-2160.
26. Pavletich NP, Pabo CO. Zinc finger-DNA recognition: Crystal structure of a Zif268-DNA complex at 2.1 A. Science 1991; 252: 809-817.
27. Dovat S, Ronni T, Russell D, et al. A common mechanism for mitotic inactivation of C2H2 zinc finger DNA-binding domains. Genes Dev 2002; 16: 2985-2990.
28. Wang JH, Nichogiannopoulou A, Wu L, et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 1996; 5: 537-549.
29. Wu L, Nichogiannopoulou A, Shortman K, et al. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 1997; 7: 483-492.
30. Winandy S, Wu P, Georgopoulos K. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 1995; 83: 289-299.
31. Kirstetter P, Thomas M, Dierich A, et al. Ikaros is critical for B cell differentiation and function. Eur J Immunol 2002; 32: 720-730.
32. Dumortier A, Jeannet R, Kirstetter P, et al. Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice. Mol Cell Biol 2006; 26: 209-220.
33. Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009; 360: 470-480.
34. Nichogiannopoulou A, Trevisan M, Neben S, et al. Defects in hemopoietic stem cell activity in Ikaros mutant mice. J Exp Med 1999; 190: 1201-1214.
35. Avitahl N, Winandy S, Friedrich C, et al. Ikaros sets thresholds for T cell activation and regulates chromosome propagation. Immunity 1999; 10: 333-343.
36. Winandy S, Wu L, Wang JH, et al. Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros. J Exp Med 1999; 190: 1039-1048.
37. Dijon M, Bardin F, Murati A, et al. The role of Ikaros in human erythroid differentiation. Blood 2008; 111: 1138-1146.
38. Pulte D, Lopez RA, Baker ST, et al. Ikaros increases normal apoptosis in adult erythroid cells. Am J Hematol 2006; 81: 12-18.
39. Thompson EC, Cobb BS, Sabbattini P, et al. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity 2007; 26: 335-344.
40. Reynaud D, Demarco IA, Reddy KL, et al. Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat Immunol 2008; 9: 927-936.